Exact Sciences
EXAS
#1148
Rank
A$29.03 B
Marketcap
A$152.09
Share price
0.00%
Change (1 day)
83.66%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): A-$2.35

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is A-$7.71. In 2022 the company made an earnings per share (EPS) of A-$5.13 a decrease over its 2021 EPS that were of A-$5.02.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$2.35-54.14%
2022A-$5.132.31%
2021A-$5.02-37.09%
2020A-$7.97674.65%
2019A-$1.03-50.69%
2018A-$2.0944%
2017A-$1.45-39.39%
2016A-$2.39-2.94%
2015A-$2.4637.1%
2014A-$1.8079.71%
2013A-$1.00-21.59%
2012A-$1.2862.96%
2011A-$0.7892.86%
2010A-$0.41-3.45%
2009A-$0.42-19.44%
2008A-$0.52-18.18%
2007A-$0.64-10.2%
2006A-$0.71-10.91%
2005A-$0.80-24.66%
2004A-$1.06-51.33%
2003A-$2.17-7.41%
2002A-$2.3511.72%
2001A-$2.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.76-135.77%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$2.09-127.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$0.49-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$1.73-77.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$73.79 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA